|
Volumn 112, Issue 428, 2005, Pages 11-13
|
Neuropharmacological basis of combining antidepressants
|
Author keywords
Antidepressants; Depression; Drug combinations; Neuropharmacology; Noradrenergic; Serotonergic
|
Indexed keywords
AMFEBUTAMONE;
ANTIDEPRESSANT AGENT;
DEXAMPHETAMINE;
DOPAMINE RECEPTOR STIMULATING AGENT;
MAPROTILINE;
MIRTAZAPINE;
NEFAZODONE;
NEUROLEPTIC AGENT;
NORTRIPTYLINE;
REBOXETINE;
SEROTONIN UPTAKE INHIBITOR;
TRAZODONE;
VENLAFAXINE;
DOPAMINE;
NORADRENALIN;
SEROTONIN;
CONFERENCE PAPER;
DOPAMINERGIC SYSTEM;
DRUG EFFICACY;
DRUG POTENTIATION;
EXPERIENCE;
HUMAN;
LITERATURE;
MEDICAL INFORMATION;
NEUROPHARMACOLOGY;
NORADRENERGIC SYSTEM;
PRESCRIPTION;
PUBLICATION;
SEROTONINERGIC SYSTEM;
CLINICAL PRACTICE;
DEPRESSION;
DRUG COMBINATION;
DRUG EFFECT;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
PSYCHOLOGICAL ASPECT;
REVIEW;
SYNAPTIC TRANSMISSION;
ANTIDEPRESSIVE AGENTS;
DEPRESSIVE DISORDER;
DOPAMINE;
DRUG SYNERGISM;
DRUG THERAPY, COMBINATION;
HUMANS;
NEUROPHARMACOLOGY;
NOREPINEPHRINE;
PHYSICIAN'S PRACTICE PATTERNS;
SEROTONIN;
SYNAPTIC TRANSMISSION;
|
EID: 29044437265
PISSN: 00651591
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (17)
|
References (3)
|